DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
Details
- Status
- Prescription
- First Approved
- 2003-06-30
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) Approval History
What DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) Treats
1 indicationsDICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) is approved for 1 conditions since its original approval in 2003. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Irritable Bowel Syndrome
Drugs Similar to DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE)
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
DICYCLOMINE HYDROCHLORIDE (PRESERVATIVE FREE) FDA Label Details
ProIndications & Usage
Dicyclomine hydrochloride capsules, USP are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.